Business Segments Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 02:21:10 09/12/2025 pm IST			5-day change	1st Jan Change
2,031.00 ^DKK	-1.22%		+0.20%	+36.55%

01:22pm	Genmab shares encouraging early-stage data on epcoritamab for RT patients	RE
12:00pm	Genmab Presents Promising Data for Epcoritamab in Richter's Transformation	FW

Sales 2024 by Business Segment

See more © MarketScreener.com

Sales 2024 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (DKK)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Biological Products
Biotechnology						1.01TCr	848.2Cr	1.46TCr	1.65TCr	2.15TCr
Total Assets						2.11TCr	2.46TCr	3.03TCr	3.53TCr	4.58TCr
Interest Expense						-1Cr	-1.3Cr	-2.1Cr	-2.7Cr	-12Cr
Income Tax Expense						114.6Cr	98Cr	151.3Cr	128.5Cr	132Cr
CAPEX						-31Cr	-25Cr	-32Cr	-37Cr	-19Cr
EBT						590.4Cr	398.3Cr	703.5Cr	563.7Cr	916.4Cr
D&A						27Cr	30Cr	40Cr	24Cr	41Cr
Operating Income						631.3Cr	301.8Cr	635.7Cr	532.1Cr	670.3Cr
Net Income						475.8Cr	300.8Cr	552.2Cr	435.2Cr	784.4Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (DKK)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Denmark						1.01TCr	848.2Cr	1.46TCr	1.61TCr	1.98TCr
Total Assets						34Cr	27Cr	21Cr	50Cr	1.27TCr
United States of America						-	-	-	38Cr	90Cr
Total Assets						37Cr	47Cr	44Cr	38Cr	319.6Cr
Total Assets						38Cr	42Cr	79Cr	87Cr	77Cr
Japan						-	-	-	4.1Cr	84Cr
Total Assets						-	9.5Cr	7Cr	5.6Cr	10Cr
Total Assets						-	-	-	-	4.8Cr

As early as today, start finding the best investment opportunities!